ovarian cancer

Tesaro CEO Says Its Drug 'Will Get There' — Analysts Strongly Disagree
Investors.com
Sat, 08/4/18 - 11:51 am
Tesaro
Zejula
ovarian cancer
Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case
TheStreet.com
Fri, 07/13/18 - 09:38 am
JNJ
ovarian cancer
AstraZeneca, Merck eye wider cancer drug use after study success
Yahoo/Reuters
Wed, 06/27/18 - 09:42 am
AstraZeneca
Merck
Lynparza
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Tue, 06/26/18 - 09:43 am
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Tue, 06/26/18 - 09:23 am
Arcus Biosciences
Infinity Pharmaceuticals
breast cancer
ovarian cancer
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
CP Wire
Thu, 05/17/18 - 12:03 pm
BeiGene
pamiparib
ovarian cancer
China
clinical trials
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
Thu, 05/17/18 - 09:53 am
BeiGene
pamiparib
ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Fri, 04/27/18 - 01:18 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Fri, 04/27/18 - 01:19 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
Boston Scientific acquires NVision Medical in $275m deal
Mass Device
Mon, 04/16/18 - 10:33 am
Boston Scientific
NVision Medical
M&A
devices
diagnostics
ovarian cancer
Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
CP Wire
Fri, 04/6/18 - 02:46 pm
Clovis Oncology
Rubraca
ovarian cancer
Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer
Fri, 04/6/18 - 02:45 pm
Clovis Oncology
Rubraca
ovarian cancer
Tesaro Wants a Stronger Grip in Ovarian Cancer
Yahoo/Motley Fool
Tue, 03/27/18 - 10:10 pm
Tesaro
AstraZeneca
Clovis Oncology
ovarian cancer
Zejula
Rubraca
Lynparza
AstraZeneca Goes Up Against 2 Cancer Upstarts
Motley Fool
Sat, 03/10/18 - 09:17 am
AstraZeneca
Clovis Oncology
PARP inhibitors
Lynparza
ovarian cancer
breast cancer
Rubraca
Zejula
Release: Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma in the Ovarian and Breast Cancer Spaces
CP Wire
Fri, 03/2/18 - 09:44 am
Skyline Medical
Helomics
GLG Pharma
ovarian cancer
breast cancer
ascites
Release: Skyline Medical and Helomics Announce a Joint Strategic Partnership with GLG Pharma in the Ovarian and Breast Cancer Spaces
Fri, 03/2/18 - 09:42 am
Skyline Medical
Helomics
GLG Pharma
ovarian cancer
breast cancer
ascites
Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents
CNBC
Tue, 02/6/18 - 11:47 am
JNJ
ovarian cancer
Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma
Endpoints
Sat, 01/20/18 - 02:56 pm
AstraZeneca
Lynparza
Merck
ovarian cancer
asthma
Japan
Fasenra
EA Pharma
elobixibat
PharmaMar stock tanks after PhIII ovarian cancer study flops
Endpoints
Sat, 01/20/18 - 02:53 pm
PharmaMar
ovarian cancer
clinical trials
Zepsyre
These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide

Pages